Blog

Bloom Energy Corporation BE is expected to register an improvement in both top and bottom lines when it reports first-quarter 2025 results on April 30, after market close. (See the Zacks Earnings

Sysco Corporation SYY has delivered third-quarter fiscal 2025 results, wherein the top line increased and the bottom line remained flat year over year. Both sales and earnings lagged the Zacks

Both Docusign DOCU and Coherent Corp. COHR are innovative technology companies reorienting their businesses strategically to seize emerging growth opportunities. DOCU is incorporating AI into its

Property and casualty insurance provider The Allstate Corporation ALL is set to report its first-quarter 2025 results on April 30, 2025, after the closing bell. The Zacks Consensus Estimate for the

Payments giant Mastercard Incorporated MA is set to report first-quarter 2025 results on May 1, 2025, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings

AdaptHealth Corp. (AHCO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates

Astellas Pharma Inc. (ALPMY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings

FirstCash Holdings (FCFS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates --

GeneDx Holdings Corp. (WGS) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces

Alignment Healthcare (ALHC) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings

Middlefield Banc Corp. (MBCN) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings

CyberArk (CYBR) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even

1st Source (SRCE) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the

Investors might want to bet on TripAdvisor (TRIP), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of

First Financial Bancorp (FFBC) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even

We expect investors to focus on the sales performance of Corcept Therapeutics’ CORT sole-marketed drug, Korlym (mifepristone), which is approved for treating Cushing's syndrome or endogenous

Uber Technologies UBER and Lyft LYFT are two well-known names in the ride-hailing space. The companies have played a big part in revolutionizing the transportation industry with their innovative